IBB Holdings Information

IBB is an equity ETF with a total of 256 individual holdings. The top holdings are Amgen stock at 7.56%, Vertex Pharmaceuticals at 7.54%, Gilead Sciences at 7.29%, Regeneron Pharmaceuticals at 5.81%, and Alnylam Pharmaceuticals at 5.43%.

Total Holdings

256

Top 10 Percentage

48.04%

Asset Class

Equity

ETF Category

Health

Assets

6.15B

PE Ratio

18.80

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	AMGN	Amgen Inc.	7.56%	1,577,516
2	VRTX	Vertex Pharmaceuticals Incorporated	7.54%	1,160,699
3	GILD	Gilead Sciences, Inc.	7.29%	4,017,606
4	REGN	Regeneron Pharmaceuticals, Inc.	5.81%	601,594
5	ALNY	Alnylam Pharmaceuticals, Inc.	5.43%	739,376
6	IQV	IQVIA Holdings Inc.	3.30%	992,719
7	ARGX	argenx SE	3.26%	253,409
8	INSM	Insmed Incorporated	3.08%	1,217,617
9	MTD	Mettler-Toledo International Inc.	2.55%	120,455
10	BIIB	Biogen Inc.	2.22%	862,015
11	NTRA	Natera, Inc.	2.10%	779,342
12	ONC	BeOne Medicines AG	2.03%	366,970
13	UTHR	United Therapeutics Corporation	1.88%	257,705
14	WAT	Waters Corporation	1.85%	349,862
15	INCY	Incyte Corporation	1.59%	1,136,491
16	ILMN	Illumina, Inc.	1.45%	880,211
17	GMAB	Genmab A/S	1.44%	2,667,165
18	NBIX	Neurocrine Biosciences, Inc.	1.25%	568,384
19	MEDP	Medpace Holdings, Inc.	1.15%	133,629
20	IONS	Ionis Pharmaceuticals, Inc.	1.04%	931,131
21	BMRN	BioMarin Pharmaceutical Inc.	0.99%	1,114,070
22	EXEL	Exelixis, Inc.	0.99%	1,535,317
23	MRNA	Moderna, Inc.	0.93%	2,023,318
24	TECH	Bio-Techne Corporation	0.92%	905,342
25	MDGL	Madrigal Pharmaceuticals, Inc.	0.85%	118,754

Showing 25 of 256 holdings

Subscribe to see the full list

Upgrade Now

As of Oct 3, 2025